DE60133879D1 - Phenanthridin -n- oxide - Google Patents

Phenanthridin -n- oxide

Info

Publication number
DE60133879D1
DE60133879D1 DE60133879T DE60133879T DE60133879D1 DE 60133879 D1 DE60133879 D1 DE 60133879D1 DE 60133879 T DE60133879 T DE 60133879T DE 60133879 T DE60133879 T DE 60133879T DE 60133879 D1 DE60133879 D1 DE 60133879D1
Authority
DE
Germany
Prior art keywords
alkoxy
substituted
phenanthridine
oxide
cycloalkylmethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60133879T
Other languages
English (en)
Inventor
Dieter Flockerzi
Gerhard Grundler
Armin Hatzelmann
Daniela Bundschuh
Hans-Peter Kley
Beate Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Nycomed GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed GmbH filed Critical Nycomed GmbH
Application granted granted Critical
Publication of DE60133879D1 publication Critical patent/DE60133879D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DE60133879T 2000-01-11 2001-01-10 Phenanthridin -n- oxide Expired - Fee Related DE60133879D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00100482 2000-01-11
PCT/EP2001/000223 WO2001051470A1 (en) 2000-01-11 2001-01-10 Phenanthridine-n-oxides

Publications (1)

Publication Number Publication Date
DE60133879D1 true DE60133879D1 (de) 2008-06-19

Family

ID=8167598

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60133879T Expired - Fee Related DE60133879D1 (de) 2000-01-11 2001-01-10 Phenanthridin -n- oxide

Country Status (8)

Country Link
US (1) US6630483B2 (de)
EP (1) EP1250325B1 (de)
JP (1) JP2003519686A (de)
AT (1) ATE394378T1 (de)
AU (1) AU782908B2 (de)
CA (1) CA2396026A1 (de)
DE (1) DE60133879D1 (de)
WO (1) WO2001051470A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1303506T1 (en) 2000-07-14 2005-06-30 Altana Pharma Ag 6-heteroarylphenanthridines
DE60310576T2 (de) * 2002-08-29 2007-10-31 Altana Pharma Ag 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
ATE353217T1 (de) * 2002-08-29 2007-02-15 Altana Pharma Ag 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
EA017282B1 (ru) 2004-03-03 2012-11-30 Никомед Гмбх Производное гидрокси-6-гетероарилфенантридина и его применение в качестве ингибитора pde4
ES2337083T3 (es) 2005-03-02 2010-04-20 Nycomed Gmbh (2r,4ar,10br)-6-(2,6-dimetoxipiridin-3-il)-9-exoti-8-metoxi-1,2,3,4,4a,10b-hexahidrofenantridin-2-ol, sal de hc1.
JP4643543B2 (ja) * 2006-11-10 2011-03-02 株式会社東芝 キャッシュ一貫性保証機能を有するストレージクラスタシステム
WO2009043784A1 (en) 2007-10-04 2009-04-09 F. Hoffmann-La Roche Ag Cyclopropyl aryl amide derivatives and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761403A (en) 1986-04-09 1988-08-02 Abbott Laboratories Lipoxygenase inhibiting compounds
EE03523B1 (et) 1996-01-31 2001-10-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
JP4141501B2 (ja) * 1996-03-26 2008-08-27 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の６位置換フェナントリジン
US6127378A (en) 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
CZ293725B6 (cs) 1997-07-25 2004-07-14 Altana Pharma Ag Tetrazolové deriváty
JP2001510827A (ja) * 1997-07-25 2001-08-07 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 置換６−フェニルフェナントリジン
US6306869B1 (en) 1998-05-05 2001-10-23 Byk Gulden Lomberg Chemische Febrik Gmbh N-oxides
SI1109810T1 (en) 1998-08-31 2004-12-31 Altana Pharma Ag Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
JP2003502278A (ja) 1999-01-15 2003-01-21 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 新規のｎ−オキシド
PT1147087E (pt) 1999-01-15 2005-09-30 Altana Pharma Ag Feantridina-n-oxidos com actividade de inibicao de pde-iv

Also Published As

Publication number Publication date
WO2001051470A1 (en) 2001-07-19
ATE394378T1 (de) 2008-05-15
AU3728301A (en) 2001-07-24
US6630483B2 (en) 2003-10-07
EP1250325B1 (de) 2008-05-07
CA2396026A1 (en) 2001-07-19
EP1250325A1 (de) 2002-10-23
JP2003519686A (ja) 2003-06-24
AU782908B2 (en) 2005-09-08
US20030105123A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
WO2005087745A8 (en) Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
WO2005087744A8 (en) Novel thio-containing hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
ATE233735T1 (de) Neue phenanthridine
HK1078850A1 (en) Novel alkoxypyridine-derivatives
AU2002328972A1 (en) Piperidine derivatives as antibacterial agents
BG105561A (en) Phenylphenanthridines with pde-iv inhibiting activity
DE59708265D1 (de) Neue in 6-position substituierte phenanthridine
DK1147103T3 (da) Phenanthridin-N-oxider med PDE-IV-inhiberende aktivitet
AU2001269688A1 (en) Combination containing an antifolate and methylmalonic acid lowering agent
DE60133879D1 (de) Phenanthridin -n- oxide
DE60020079D1 (de) Phenanthridine-n-oxide mit pde-iv hemmender wirkung
WO2001078653A3 (en) Graft rejection inhibition with ccr2 inhibitors
WO2005084104A3 (en) Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
AU2289400A (en) 6-arylphenanthridines with pde-iv inhibiting activity
NO20064220L (no) Nye heterocyklylsubstituerte hydroksy-6-fenylfenantridiner og deres anvendelse som PDE4-inhibitorer
ATE376422T1 (de) Diclazurilhaltige antiprotozoenmittel
IL144874A0 (en) Thiophene-ethyl thiourea compounds and use in the treatment of hiv
CY2582B2 (en) New imidazopyridines and oxazolopyridines
AU2002224431A1 (en) 2-substituted heterocyclic compounds and their use in treating multidrug resistance
NZ331374A (en) Phenanthridine compounds and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee